Results: 1915

Covid-19 y responsabilidad civil médica: desafíos de una enfermedad desconocida que devino en pandemia

Acta bioeth; 26 (2), 2020
Resumen La emergencia sanitaria provocada por el coronavirus evidencia que los regímenes de responsabilidad deben ser capaces de diferenciar los instrumentos conceptuales disponibles para lidiar con una enfermedad nueva que, además, devino en pandemia. Este trabajo postula que, tratándose de enfermeda...

Desafíos de la reanimación cardiopulmonar avanzada en pacientes con la COVID-19
Challenges in the advanced cardiopulmonary resuscitation in patients with the COVID-19

Medisan; 24 (5), 2020
Con este trabajo se pretende complementar las normativas generales impuestas por las autoridades sanitarias cubanas en cuanto a la reanimación cardiopulmonar, donde es necesario hacer hincapié, desde el punto de vista individual, para lograr una correcta actuación frente a la COVID-19. La reanimación...

Clinical risk profile associated with SARS-CoV-2 infection and complications in the emergency area of a pediatric COVID-19 center

Abstract Background: In February 2020, the disease caused by the novel coronavirus (SARS-CoV-2), was classified as a pandemic. In the pediatric population, coronavirus disease (COVID)-19 has a reported mortality of less than 6% in complicated cases; however, the clinical characteristics and severity are...

Saliva as a promising biofluid for SARS-CoV-2 detection during the early stages of infection

Abstract Background: Diagnostic testing for coronavirus disease (COVID)-19 is performed using nasopharyngeal swabs. This type of sampling is uncomfortable for the patient, dangerous for health workers, and its high demand has led to a global shortage of swabs. One of the alternative specimens is saliva....

COVID-19 pandemic: challenges ahead

Abstract Since December 2019, health systems worldwide have faced the pandemic caused by the new severe acute respiratory syndrome coronavirus 2. The pandemic began in China and has spread throughout the world. This new coronavirus has a high transmission capacity and elevated lethality in people over 60...

SARS-CoV-2: previous coronaviruses, immune response, and development of vaccines

Abstract Since the emergence of the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in China at the end of 2019, when its characteristics were practically unknown, one aspect was evident: its high contagion rate. This high infection rate resulted in the spread of the virus in China, Euro...

SARS-CoV-2 and influenza: a comparative overview and treatment implications

Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Alphainfluenzavirus are RNA viruses that cause coronavirus disease-19 and influenza, respectively. Both viruses infect the respiratory tract, show similar symptoms, and use surface proteins to infect the host. Influenza requires he...

Considerations on the use of antihypertensive blockers of the renin-angiotensin system in adults and children in the face of the COVID-19 pandemic

Abstract As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected patients with hypertension and other cardiovascular comorbidities develop more severe coronavirus disease (COVID)-19 and are at high risk of death, a controversy arose about the use of antihypertensives as angiotensin-conve...

Immune response in SARS-CoV-2 infection: the role of interferons type I and type III

Braz. j. infect. dis; 24 (5), 2020
Abstract Background There is scarce information on the human immune response to the SARS-CoV-2 infection, and on the exacerbated inflammatory reaction observed in severe COVID-19 cases. Objective To review the available evidence on the role of interferons type I and type III to SARS-CoV-2 infection. M...